Integra Lifesciences Holdings (IART) Share-based Compensation (2009 - 2026)

Integra Lifesciences Holdings has disclosed Share-based Compensation across 18 years of filings, most recently posting $5.8 million for Q2 2026.

• In Q2 2026, Share-based Compensation rose 16.21% year-over-year to $5.8 million; the TTM figure through Jun 2026 stood at $22.4 million (up 19.94% YoY), while the FY2025 annual figure was $18.6 million, down 23.77% from the prior year.
• Share-based Compensation came in at $5.8 million for Q2 2026 at Integra Lifesciences Holdings, up from $5.2 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $14.0 million in Q2 2022 to a low of $1.1 million in Q3 2022.
• Average Share-based Compensation over 5 years is $5.7 million, with a median of $5.6 million recorded in 2024.
• Year-over-year, Share-based Compensation sank 85.26% in 2022 and surged 378.02% in 2023.
• Over 5 years, Share-based Compensation stood at $3.4 million in 2022, then soared by 71.44% to $5.8 million in 2023, then advanced by 23.46% to $7.2 million in 2024, then retreated by 18.37% to $5.8 million in 2025, then grew by 0.1% to $5.8 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $5.8 million in Q2 2026, $5.2 million in Q1 2026, and $5.8 million in Q4 2025.